Hydrogenation of Carbon Dioxide to Formate by Noble Metal Catalysts Supported on a Chemically Stable Lanthanum Rod-Metal-Organic Framework.

The conversion of carbon dioxide to formate is of great importance for hydrogen storage as well as being a step to access an array of olefins. Herein, we have prepared a JMS-5 metal-organic framework (MOF) using a bipyridyl dicarboxylate linker, with the molecular formula [La2(bpdc)3/2(dmf)2(OAc)3]·dmf. The MOF was functionalized by cyclometalation using Pd(II), Pt(II), Ru(II), Rh(III), and Ir(III) complexes. All metal catalysts supported on JMS-5 showed activity for CO2 hydrogenation to formate, with Rh(III)@JMS-5a and Ir(III)@JMS-5a yielding 4319 and 5473 TON, respectively. X-ray photoelectron spectroscopy of the most active catalyst Ir(III)@JMS-5a revealed that the iridium binding energies shifted to lower values, consistent with formation of Ir-H active species during catalysis. The transmission electron microscopy images of the recovered catalysts of Ir(III)@JMS-5a and Rh(III)@JMS-5a did not show any nanoparticles. This suggests that the catalytic activity observed was due to Ir(III) and Rh(III). The high activity displayed by Ir(III)@JMS-5a and Rh(III)@JMS-5a compared to using the Ir(III) and Rh(III) complexes on their own is attributed to the stabilization of the Ir(III) and Rh(III) on the nitrogen and carbon atom of the MOF backbone.

Cinnamoyl-Oxaborole Amides: Synthesis and Their in Vitro Biological Activity.

Due to the increased interest in their application in the treatment of infectious diseases, boron-containing compounds have received a significant coverage in the literature. Herein, a small set of novel cinnamoly-oxaborole amides were synthesized and screened against nagana Trypanosoma brucei brucei for antitrypanosomal activity. Compound 5g emerged as a new hit with an in vitro IC50 value of 0.086 µM against T. b. brucei without obvious inhibitory activity against HeLa cell lines. The same series was also screened against other human pathogens, including Mycobacterium tuberculosis, the causative agent of tuberculosis (TB), for which moderate to weak activity (10 to >125 µM) was observed. Similarly, these compounds exhibited moderate activity against the human protozoal pathogen Trichomonas vaginalis with no observed effect on common microbiome bacterial species. The cross-species inhibitory activity presents the possibility of these compounds serving as broad-spectrum antibiotics for these prevalent three human pathogens.

Two novel metal-organic frameworks functionalised with pentamethylcyclopentadienyl iridium(III) chloride for catalytic conversion of carbon dioxide to formate.

Hydrogenation of CO2 to formate is a vital reaction, because formate is an excellent hydrogen carrier, which yields blue hydrogen. Blue hydrogen is comparatively cheaper and attractive as the world envisions the hydrogen economy. In this work, two isostructural lanthanide-based MOFs (JMS-6 and JMS-7 [Ln(bpdc)3/2(dmf)2(H2O)2]n) were prepared and used as support materials for molecular catalysts. The bipyridyl MOF backbone were functionalised using pentamethylcyclopentadienyl iridium(III) chloride to give Ir(III)@JMS-6a and Ir(III)@JMS-7a. XPS of the functionalised MOFs show downfield shifts in the N 1s binding energy indicating successful grafting of the complex to the MOF. Hydrogenation experiments in the presence of an organic base showed that the functionalised MOFs were active towards converting CO2 to formate. Ir(III)@JMS-6a and Ir(III)@JMS-7a exhibited the highest turnover numbers of 813 and 621 respectively. ICP-OES indicated insignificant leaching during catalysis. TEM images and XPS data of the recovered catalyst ruled out the presence of Ir(0), confirming that the activity observed was attributed to the molecular Iridium(III) centres.